Hepatitis B virus resistance to adefovir in a nucleotide naive patient with chronic hepatitis B virus infection [7]

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 4, 2007, Pages 807-809

  Laoi, B Ni ^a,b   Herra, C ^c   Norris, S ^a   Crowley, B ^a,d  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

HBV; Lamivudine treatment; Primary adefovir resistance

Indexed keywords

ADEFOVIR; ALANINE; ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; LEUCINE; METHIONINE; RNA DIRECTED DNA POLYMERASE; TENOFOVIR; VALINE; VIRUS DNA; ADENINE; ANTIVIRUS AGENT; DRUG DERIVATIVE; PHOSPHONIC ACID DERIVATIVE;

ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IRELAND; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; UNSPECIFIED SIDE EFFECT; VIRUS REPLICATION; CLINICAL TRIAL; DRUG EFFECT; GENETICS; GENOTYPE; LIVER; MUTATION; PATHOLOGY; VIROLOGY;

ADENINE; ADULT; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MUTATION; PHOSPHONIC ACIDS; VIRUS REPLICATION;

EID: 34250018375     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm026     Document Type: Letter

References (6)

1. Liaw YF, Leung NW, Chang TT et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Hepatitis Lamivudine Study Group. Gastroenterology 2000; 119: 172-80.
2. Locamini S, Qi X, Arterburn S et al. Incidence and predictors of emergence of HBV mutations associated with ADV resistance during 4 years of adefovir therapy for patients with chronic HBV. J Hepatol 2005; 42 Suppl 2: A36.
3. Delaney WE IV, Yang H, Westland CE et al. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J Virol 2003; 77: 11833-41.
4. Schildgen O, Sirma H, Funk A et al. Variant of hepatitis B virus with primary resistance to adefovir. N Engl J Med 2006; 354: 1807-12.
5. Aye TT, Bartholomeusz A, Shaw T et al. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J Hepatol 1997; 26: 1148-53.
6. Yeh CT, Chien RN, Chu CM et al. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology 2000; 31: 1318-26.